These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 32505840

  • 1. Xiaoaiping injection enhances paclitaxel efficacy in ovarian cancer via pregnane X receptor and its downstream molecules.
    Zhang XQ, Ding YW, Chen JJ, Xiao X, Zhang W, Zhou L, Kong QW, Shi MZ, Yang J, Jiang B, Guo C, Han YL.
    J Ethnopharmacol; 2020 Oct 28; 261():113067. PubMed ID: 32505840
    [Abstract] [Full Text] [Related]

  • 2. Pregnane X receptors regulate CYP2C8 and P-glycoprotein to impact on the resistance of NSCLC cells to Taxol.
    Chen Y, Huang W, Chen F, Hu G, Li F, Li J, Xuan A.
    Cancer Med; 2016 Dec 28; 5(12):3564-3571. PubMed ID: 27878971
    [Abstract] [Full Text] [Related]

  • 3. Gancao (Glycyrrhizae Radix) provides the main contribution to Shaoyao-Gancao decoction on enhancements of CYP3A4 and MDR1 expression via pregnane X receptor pathway in vitro.
    Feng D, Tang T, Fan R, Luo J, Cui H, Wang Y, Gan P.
    BMC Complement Altern Med; 2018 Dec 29; 18(1):345. PubMed ID: 30594244
    [Abstract] [Full Text] [Related]

  • 4. Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells.
    Li X, He Y, Wei L, Zhang J, Li X, Cui W, Zhang S.
    J Pharm Pharmacol; 2021 Mar 08; 73(4):545-552. PubMed ID: 33793827
    [Abstract] [Full Text] [Related]

  • 5. Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo.
    Kong QW, Yang J, Li D, Ding YW, Hu YJ, Xue XC, Shi MZ, Jiang B, Zhou YY, Zhang M, Hu JD, Guo C, Chen JJ, Han YL.
    J Ethnopharmacol; 2023 Jan 10; 300():115728. PubMed ID: 36126783
    [Abstract] [Full Text] [Related]

  • 6. [Inhibitory effect of a Chinese medicine Xiaoaiping combined with cisplatin on the proliferation, invasion and apoptosis in ovarian cancer HO-8910 PM cells in vitro and in vivo].
    Zheng A, Li T, Chen Y, Fang J, Zhang Y, Feng J.
    Zhonghua Zhong Liu Za Zhi; 2016 Jan 10; 38(1):11-6. PubMed ID: 26796800
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of pregnane X receptor pathway contributes to the cell growth inhibition and apoptosis of anticancer agents in ovarian cancer cells.
    Masuyama H, Nakamura K, Nobumoto E, Hiramatsu Y.
    Int J Oncol; 2016 Sep 10; 49(3):1211-20. PubMed ID: 27572875
    [Abstract] [Full Text] [Related]

  • 8. Tenacigenin B ester derivatives from Marsdenia tenacissima actively inhibited CYP3A4 and enhanced in vivo antitumor activity of paclitaxel.
    Xie B, Lu YY, Luo ZH, Qu Z, Zheng CG, Huang XA, Zhou HY, Hu YJ, Shen XL.
    J Ethnopharmacol; 2019 May 10; 235():309-319. PubMed ID: 30772481
    [Abstract] [Full Text] [Related]

  • 9. Metformin and epithelial ovarian cancer therapeutics.
    Patel S, Kumar L, Singh N.
    Cell Oncol (Dordr); 2015 Oct 10; 38(5):365-75. PubMed ID: 26266765
    [Abstract] [Full Text] [Related]

  • 10. Antitumor Effect of C21 Steroidal Glycosides on Adenoid Cystic Carcinoma Cell Line SACC83.
    Wang Q, Cao J, Wang P, Ge M.
    Clin Lab; 2015 Oct 10; 61(10):1553-60. PubMed ID: 26642719
    [Abstract] [Full Text] [Related]

  • 11. The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.
    Le XF, Mao W, He G, Claret FX, Xia W, Ahmed AA, Hung MC, Siddik ZH, Bast RC.
    J Natl Cancer Inst; 2011 Sep 21; 103(18):1403-22. PubMed ID: 21813412
    [Abstract] [Full Text] [Related]

  • 12. TGF-β induced chemoresistance in liver cancer is modulated by xenobiotic nuclear receptor PXR.
    Bhagyaraj E, Ahuja N, Kumar S, Tiwari D, Gupta S, Nanduri R, Gupta P.
    Cell Cycle; 2019 Dec 21; 18(24):3589-3602. PubMed ID: 31739702
    [Abstract] [Full Text] [Related]

  • 13. Tumor suppressor BLU promotes paclitaxel antitumor activity by inducing apoptosis through the down-regulation of Bcl-2 expression in tumorigenesis.
    Park ST, Byun HJ, Kim BR, Dong SM, Park SH, Jang PR, Rho SB.
    Biochem Biophys Res Commun; 2013 May 24; 435(1):153-9. PubMed ID: 23628417
    [Abstract] [Full Text] [Related]

  • 14. Synthetic paclitaxel-octreotide conjugate reversing the resistance of A2780/Taxol to paclitaxel in xenografted tumor in nude mice.
    Chen X, Zhang XY, Shen Y, Fan LL, Ren ML, Wu YP.
    Oncotarget; 2016 Dec 13; 7(50):83451-83461. PubMed ID: 27825139
    [Abstract] [Full Text] [Related]

  • 15. The Effect of Thymoquinone on Apoptosis of SK-OV-3 Ovarian Cancer Cell by Regulation of Bcl-2 and Bax.
    Liu X, Dong J, Cai W, Pan Y, Li R, Li B.
    Int J Gynecol Cancer; 2017 Oct 13; 27(8):1596-1601. PubMed ID: 28692636
    [Abstract] [Full Text] [Related]

  • 16. Xiaoaiping combined with cisplatin can inhibit proliferation and invasion and induce cell cycle arrest and apoptosis in human ovarian cancer cell lines.
    Zheng AW, Chen YQ, Fang J, Zhang YL, Jia DD.
    Biomed Pharmacother; 2017 May 13; 89():1172-1177. PubMed ID: 28320083
    [Abstract] [Full Text] [Related]

  • 17. Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivo.
    Mao HL, Pang Y, Zhang X, Yang F, Zheng J, Wang Y, Liu P.
    Oncol Rep; 2013 Feb 13; 29(2):515-22. PubMed ID: 23151974
    [Abstract] [Full Text] [Related]

  • 18. Intestinal human colon adenocarcinoma cell line LS180 is an excellent model to study pregnane X receptor, but not constitutive androstane receptor, mediated CYP3A4 and multidrug resistance transporter 1 induction: studies with anti-human immunodeficiency virus protease inhibitors.
    Gupta A, Mugundu GM, Desai PB, Thummel KE, Unadkat JD.
    Drug Metab Dispos; 2008 Jun 13; 36(6):1172-80. PubMed ID: 18332086
    [Abstract] [Full Text] [Related]

  • 19. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway.
    Fu J, Zhu SH, Xu HB, Xu YQ, Wang X, Wang J, Kong PS.
    J Ethnopharmacol; 2020 Oct 28; 261():113071. PubMed ID: 32603676
    [Abstract] [Full Text] [Related]

  • 20. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
    Witham J, Valenti MR, De-Haven-Brandon AK, Vidot S, Eccles SA, Kaye SB, Richardson A.
    Clin Cancer Res; 2007 Dec 01; 13(23):7191-8. PubMed ID: 18056200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.